Secnidazole

塞克硝唑

Report date: 2022/01/14 13:23:58
NMEQIDP

Base Information

Drug NameSecnidazole
Drug Alias Name另丁硝唑SecnidazolumSecnidazolSecnolDeprozol +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Nitroimidazole antibiotics
Mechanisms of ActionDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsTrichomonas InfectionsGiardiasisVaginosis, Bacterial
Global Approved IndicationsTrichomonas InfectionsGiardiasisVaginosis, Bacterial
Approved Indications in ChinaTrichomonas InfectionsGiardiasisVaginosis, Bacterial
Original Approved Country/TerritorySwitzerland
Original Approved Date1980/01/01
Country/TerritoryUnited StatesSwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofiRhône-Poulenc Rorer
China Registration ClassN/A

Develop Information

Active CompaniesExeltisEvofem IncEthypharm Sa
Inactive CompaniesIndiana UniversityLupin Pharmaceuticals IncLupin Research Inc +[4] 
Active IndicationsTrichomonas InfectionsGiardiasisVaginosis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeP01AB07
Related LinksWikipediaDrugBankKEGG